Literature DB >> 9512401

Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells.

B Draczynska-Lusiak1, Y M Chen, A Y Sun.   

Abstract

Oxidative stress in the central nervous system may cause oxidation of lipoproteins. The oxidized lipoproteins may in turn damage cellular and subcellular membranes and other biomolecules, leading to tissue injury and cell death. Recently, we have demonstrated that oxidized LDL and VLDL induced cell death in a dose-dependent manner. The present study examined the possible signal transduction cascade leading to cell death by oxLDL and oxVLDL in PC12 cells. Using the electrophoretic mobility shift assay, we found that both oxLDL and oxVLDL activated the binding of NF-kappaB to the consensus sequence in the promoter region of the target genes, followed by apopototic cell death. Resveratrol protects the cells from both the activation of NF-kappa-B/ DNA binding activity and apoptotic cell death. Results indicated that oxidized lipoproteins may serve as an oxidative mediator and may activate apoptosis through a nuclear signalling pathway contributing to the pathology in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512401     DOI: 10.1097/00001756-199802160-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

Review 2.  Kainic acid-mediated excitotoxicity as a model for neurodegeneration.

Authors:  Qun Wang; Sue Yu; Agnes Simonyi; Grace Y Sun; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Role of endocytosis in the transactivation of nuclear factor-kappaB by oxidized low-density lipoprotein.

Authors:  C Y Han; S Y Park; Y K Pak
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

Review 4.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 5.  Resveratrol and Alzheimer's Disease: Mechanistic Insights.

Authors:  Touqeer Ahmed; Sehrish Javed; Sana Javed; Ameema Tariq; Dunja Šamec; Silvia Tejada; Seyed Fazel Nabavi; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

6.  Oxidized lipoproteins, beta amyloid peptides and Alzheimer's disease.

Authors:  A Y Sun; B Draczynska-Lusiak; G Y Sun
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

7.  Resveratrol modulates phagocytosis of bacteria through an NF-kappaB-dependent gene program.

Authors:  Mitsuhiro Iyori; Hideo Kataoka; Haque Mohammad Shamsul; Kazuto Kiura; Motoaki Yasuda; Takashi Nakata; Akira Hasebe; Ken-ichiro Shibata
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

8.  Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.

Authors:  Xuxia Sui; Yanmin Liu; Qi Li; Gefei Liu; Xuhong Song; Zhongjing Su; Xiaolan Chang; Yingbi Zhou; Bin Liang; Dongyang Huang
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 9.  Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.

Authors:  Stephanie Andrade; Maria João Ramalho; Maria do Carmo Pereira; Joana A Loureiro
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.